Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma

King Faisal Specialist Hospital & Research Center

Status: Unknown

Conditions: Ewing's Sarcoma

Treatments: Drug: Vincristine, Actinomycin-D, Ifosfamide

Study type: Interventional

Funder types: Other

Identifiers

NCT00541411

RAC#2031-065

Details and patient eligibility

About

Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide combination chemotherapy in Ewing's Sarcoma

Enrollment: 10 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with Ewing's Sarcoma

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)